Global Sexually Transmitted Diseases (STD) Testing Market 2022 by Company, Regions, Type and Application, Forecast to 2028
The Sexually Transmitted Diseases (STD) Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Sexually Transmitted Diseases (STD) Testing market size is estimated to be worth US$ 80720 million in 2021 and is forecast to a readjusted size of USD 99700 million by 2028 with a CAGR of 3.1% during review period. Laboratory Testing accounting for % of the Sexually Transmitted Diseases (STD) Testing global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Chlamydia segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Sexually Transmitted Diseases (STD) Testing include ROCHE HOLDINGS, BIOMERIEUX, HOLOGIC, BECTON DICKINSON, and ORASURE, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Sexually Transmitted Diseases (STD) Testing market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Chlamydia
Syphilis
Gonorrhea
Herpes Simplex Virus
Human Papilloma Virus
Human Immunodeficiency Virus
Others
Market segment by Application, can be divided into
Laboratory Testing
Point of Care (POC) Testing
Market segment by players, this report covers
ROCHE HOLDINGS
BIOMERIEUX
HOLOGIC
BECTON DICKINSON
ORASURE
DANAHER
AFFYMETRIX
ABBOTT LABORATORIES
BIO-RAD LABORATORIES
DIASORIN
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Sexually Transmitted Diseases (STD) Testing product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Sexually Transmitted Diseases (STD) Testing, with revenue, gross margin and global market share of Sexually Transmitted Diseases (STD) Testing from 2019 to 2022.
Chapter 3, the Sexually Transmitted Diseases (STD) Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Sexually Transmitted Diseases (STD) Testing market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Sexually Transmitted Diseases (STD) Testing research findings and conclusion, appendix and data source.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Sexually Transmitted Diseases (STD) Testing
1.2 Classification of Sexually Transmitted Diseases (STD) Testing by Type
1.2.1 Overview: Global Sexually Transmitted Diseases (STD) Testing Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Sexually Transmitted Diseases (STD) Testing Revenue Market Share by Type in 2021
1.2.3 Chlamydia
1.2.4 Syphilis
1.2.5 Gonorrhea
1.2.6 Herpes Simplex Virus
1.2.7 Human Papilloma Virus
1.2.8 Human Immunodeficiency Virus
1.2.9 Others
1.3 Global Sexually Transmitted Diseases (STD) Testing Market by Application
1.3.1 Overview: Global Sexually Transmitted Diseases (STD) Testing Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Laboratory Testing
1.3.3 Point of Care (POC) Testing
1.4 Global Sexually Transmitted Diseases (STD) Testing Market Size & Forecast
1.5 Global Sexually Transmitted Diseases (STD) Testing Market Size and Forecast by Region
1.5.1 Global Sexually Transmitted Diseases (STD) Testing Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Sexually Transmitted Diseases (STD) Testing Market Size by Region, (2017-2022)
1.5.3 North America Sexually Transmitted Diseases (STD) Testing Market Size and Prospect (2017-2028)
1.5.4 Europe Sexually Transmitted Diseases (STD) Testing Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market Size and Prospect (2017-2028)
1.5.6 South America Sexually Transmitted Diseases (STD) Testing Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Sexually Transmitted Diseases (STD) Testing Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Sexually Transmitted Diseases (STD) Testing Market Drivers
1.6.2 Sexually Transmitted Diseases (STD) Testing Market Restraints
1.6.3 Sexually Transmitted Diseases (STD) Testing Trends Analysis
2 Company Profiles
2.1 ROCHE HOLDINGS
2.1.1 ROCHE HOLDINGS Details
2.1.2 ROCHE HOLDINGS Major Business
2.1.3 ROCHE HOLDINGS Sexually Transmitted Diseases (STD) Testing Product and Solutions
2.1.4 ROCHE HOLDINGS Sexually Transmitted Diseases (STD) Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 ROCHE HOLDINGS Recent Developments and Future Plans
2.2 BIOMERIEUX
2.2.1 BIOMERIEUX Details
2.2.2 BIOMERIEUX Major Business
2.2.3 BIOMERIEUX Sexually Transmitted Diseases (STD) Testing Product and Solutions
2.2.4 BIOMERIEUX Sexually Transmitted Diseases (STD) Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 BIOMERIEUX Recent Developments and Future Plans
2.3 HOLOGIC
2.3.1 HOLOGIC Details
2.3.2 HOLOGIC Major Business
2.3.3 HOLOGIC Sexually Transmitted Diseases (STD) Testing Product and Solutions
2.3.4 HOLOGIC Sexually Transmitted Diseases (STD) Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 HOLOGIC Recent Developments and Future Plans
2.4 BECTON DICKINSON
2.4.1 BECTON DICKINSON Details
2.4.2 BECTON DICKINSON Major Business
2.4.3 BECTON DICKINSON Sexually Transmitted Diseases (STD) Testing Product and Solutions
2.4.4 BECTON DICKINSON Sexually Transmitted Diseases (STD) Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 BECTON DICKINSON Recent Developments and Future Plans
2.5 ORASURE
2.5.1 ORASURE Details
2.5.2 ORASURE Major Business
2.5.3 ORASURE Sexually Transmitted Diseases (STD) Testing Product and Solutions
2.5.4 ORASURE Sexually Transmitted Diseases (STD) Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 ORASURE Recent Developments and Future Plans
2.6 DANAHER
2.6.1 DANAHER Details
2.6.2 DANAHER Major Business
2.6.3 DANAHER Sexually Transmitted Diseases (STD) Testing Product and Solutions
2.6.4 DANAHER Sexually Transmitted Diseases (STD) Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 DANAHER Recent Developments and Future Plans
2.7 AFFYMETRIX
2.7.1 AFFYMETRIX Details
2.7.2 AFFYMETRIX Major Business
2.7.3 AFFYMETRIX Sexually Transmitted Diseases (STD) Testing Product and Solutions
2.7.4 AFFYMETRIX Sexually Transmitted Diseases (STD) Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 AFFYMETRIX Recent Developments and Future Plans
2.8 ABBOTT LABORATORIES
2.8.1 ABBOTT LABORATORIES Details
2.8.2 ABBOTT LABORATORIES Major Business
2.8.3 ABBOTT LABORATORIES Sexually Transmitted Diseases (STD) Testing Product and Solutions
2.8.4 ABBOTT LABORATORIES Sexually Transmitted Diseases (STD) Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 ABBOTT LABORATORIES Recent Developments and Future Plans
2.9 BIO-RAD LABORATORIES
2.9.1 BIO-RAD LABORATORIES Details
2.9.2 BIO-RAD LABORATORIES Major Business
2.9.3 BIO-RAD LABORATORIES Sexually Transmitted Diseases (STD) Testing Product and Solutions
2.9.4 BIO-RAD LABORATORIES Sexually Transmitted Diseases (STD) Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 BIO-RAD LABORATORIES Recent Developments and Future Plans
2.10 DIASORIN
2.10.1 DIASORIN Details
2.10.2 DIASORIN Major Business
2.10.3 DIASORIN Sexually Transmitted Diseases (STD) Testing Product and Solutions
2.10.4 DIASORIN Sexually Transmitted Diseases (STD) Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 DIASORIN Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Sexually Transmitted Diseases (STD) Testing Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Sexually Transmitted Diseases (STD) Testing Players Market Share in 2021
3.2.2 Top 10 Sexually Transmitted Diseases (STD) Testing Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Sexually Transmitted Diseases (STD) Testing Players Head Office, Products and Services Provided
3.4 Sexually Transmitted Diseases (STD) Testing Mergers & Acquisitions
3.5 Sexually Transmitted Diseases (STD) Testing New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Sexually Transmitted Diseases (STD) Testing Revenue and Market Share by Type (2017-2022)
4.2 Global Sexually Transmitted Diseases (STD) Testing Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Sexually Transmitted Diseases (STD) Testing Revenue Market Share by Application (2017-2022)
5.2 Global Sexually Transmitted Diseases (STD) Testing Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Sexually Transmitted Diseases (STD) Testing Revenue by Type (2017-2028)
6.2 North America Sexually Transmitted Diseases (STD) Testing Revenue by Application (2017-2028)
6.3 North America Sexually Transmitted Diseases (STD) Testing Market Size by Country
6.3.1 North America Sexually Transmitted Diseases (STD) Testing Revenue by Country (2017-2028)
6.3.2 United States Sexually Transmitted Diseases (STD) Testing Market Size and Forecast (2017-2028)
6.3.3 Canada Sexually Transmitted Diseases (STD) Testing Market Size and Forecast (2017-2028)
6.3.4 Mexico Sexually Transmitted Diseases (STD) Testing Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Sexually Transmitted Diseases (STD) Testing Revenue by Type (2017-2028)
7.2 Europe Sexually Transmitted Diseases (STD) Testing Revenue by Application (2017-2028)
7.3 Europe Sexually Transmitted Diseases (STD) Testing Market Size by Country
7.3.1 Europe Sexually Transmitted Diseases (STD) Testing Revenue by Country (2017-2028)
7.3.2 Germany Sexually Transmitted Diseases (STD) Testing Market Size and Forecast (2017-2028)
7.3.3 France Sexually Transmitted Diseases (STD) Testing Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Sexually Transmitted Diseases (STD) Testing Market Size and Forecast (2017-2028)
7.3.5 Russia Sexually Transmitted Diseases (STD) Testing Market Size and Forecast (2017-2028)
7.3.6 Italy Sexually Transmitted Diseases (STD) Testing Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Sexually Transmitted Diseases (STD) Testing Revenue by Type (2017-2028)
8.2 Asia-Pacific Sexually Transmitted Diseases (STD) Testing Revenue by Application (2017-2028)
8.3 Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market Size by Region
8.3.1 Asia-Pacific Sexually Transmitted Diseases (STD) Testing Revenue by Region (2017-2028)
8.3.2 China Sexually Transmitted Diseases (STD) Testing Market Size and Forecast (2017-2028)
8.3.3 Japan Sexually Transmitted Diseases (STD) Testing Market Size and Forecast (2017-2028)
8.3.4 South Korea Sexually Transmitted Diseases (STD) Testing Market Size and Forecast (2017-2028)
8.3.5 India Sexually Transmitted Diseases (STD) Testing Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Sexually Transmitted Diseases (STD) Testing Market Size and Forecast (2017-2028)
8.3.7 Australia Sexually Transmitted Diseases (STD) Testing Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Sexually Transmitted Diseases (STD) Testing Revenue by Type (2017-2028)
9.2 South America Sexually Transmitted Diseases (STD) Testing Revenue by Application (2017-2028)
9.3 South America Sexually Transmitted Diseases (STD) Testing Market Size by Country
9.3.1 South America Sexually Transmitted Diseases (STD) Testing Revenue by Country (2017-2028)
9.3.2 Brazil Sexually Transmitted Diseases (STD) Testing Market Size and Forecast (2017-2028)
9.3.3 Argentina Sexually Transmitted Diseases (STD) Testing Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Sexually Transmitted Diseases (STD) Testing Revenue by Type (2017-2028)
10.2 Middle East & Africa Sexually Transmitted Diseases (STD) Testing Revenue by Application (2017-2028)
10.3 Middle East & Africa Sexually Transmitted Diseases (STD) Testing Market Size by Country
10.3.1 Middle East & Africa Sexually Transmitted Diseases (STD) Testing Revenue by Country (2017-2028)
10.3.2 Turkey Sexually Transmitted Diseases (STD) Testing Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Sexually Transmitted Diseases (STD) Testing Market Size and Forecast (2017-2028)
10.3.4 UAE Sexually Transmitted Diseases (STD) Testing Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Sexually Transmitted Diseases (STD) Testing Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Sexually Transmitted Diseases (STD) Testing Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Sexually Transmitted Diseases (STD) Testing Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Sexually Transmitted Diseases (STD) Testing Revenue (USD Million) by Region (2017-2022)
Table 5. Global Sexually Transmitted Diseases (STD) Testing Revenue Market Share by Region (2023-2028)
Table 6. ROCHE HOLDINGS Corporate Information, Head Office, and Major Competitors
Table 7. ROCHE HOLDINGS Major Business
Table 8. ROCHE HOLDINGS Sexually Transmitted Diseases (STD) Testing Product and Solutions
Table 9. ROCHE HOLDINGS Sexually Transmitted Diseases (STD) Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. BIOMERIEUX Corporate Information, Head Office, and Major Competitors
Table 11. BIOMERIEUX Major Business
Table 12. BIOMERIEUX Sexually Transmitted Diseases (STD) Testing Product and Solutions
Table 13. BIOMERIEUX Sexually Transmitted Diseases (STD) Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. HOLOGIC Corporate Information, Head Office, and Major Competitors
Table 15. HOLOGIC Major Business
Table 16. HOLOGIC Sexually Transmitted Diseases (STD) Testing Product and Solutions
Table 17. HOLOGIC Sexually Transmitted Diseases (STD) Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. BECTON DICKINSON Corporate Information, Head Office, and Major Competitors
Table 19. BECTON DICKINSON Major Business
Table 20. BECTON DICKINSON Sexually Transmitted Diseases (STD) Testing Product and Solutions
Table 21. BECTON DICKINSON Sexually Transmitted Diseases (STD) Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. ORASURE Corporate Information, Head Office, and Major Competitors
Table 23. ORASURE Major Business
Table 24. ORASURE Sexually Transmitted Diseases (STD) Testing Product and Solutions
Table 25. ORASURE Sexually Transmitted Diseases (STD) Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. DANAHER Corporate Information, Head Office, and Major Competitors
Table 27. DANAHER Major Business
Table 28. DANAHER Sexually Transmitted Diseases (STD) Testing Product and Solutions
Table 29. DANAHER Sexually Transmitted Diseases (STD) Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. AFFYMETRIX Corporate Information, Head Office, and Major Competitors
Table 31. AFFYMETRIX Major Business
Table 32. AFFYMETRIX Sexually Transmitted Diseases (STD) Testing Product and Solutions
Table 33. AFFYMETRIX Sexually Transmitted Diseases (STD) Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. ABBOTT LABORATORIES Corporate Information, Head Office, and Major Competitors
Table 35. ABBOTT LABORATORIES Major Business
Table 36. ABBOTT LABORATORIES Sexually Transmitted Diseases (STD) Testing Product and Solutions
Table 37. ABBOTT LABORATORIES Sexually Transmitted Diseases (STD) Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. BIO-RAD LABORATORIES Corporate Information, Head Office, and Major Competitors
Table 39. BIO-RAD LABORATORIES Major Business
Table 40. BIO-RAD LABORATORIES Sexually Transmitted Diseases (STD) Testing Product and Solutions
Table 41. BIO-RAD LABORATORIES Sexually Transmitted Diseases (STD) Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. DIASORIN Corporate Information, Head Office, and Major Competitors
Table 43. DIASORIN Major Business
Table 44. DIASORIN Sexually Transmitted Diseases (STD) Testing Product and Solutions
Table 45. DIASORIN Sexually Transmitted Diseases (STD) Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Global Sexually Transmitted Diseases (STD) Testing Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 47. Global Sexually Transmitted Diseases (STD) Testing Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 48. Breakdown of Sexually Transmitted Diseases (STD) Testing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 49. Sexually Transmitted Diseases (STD) Testing Players Head Office, Products and Services Provided
Table 50. Sexually Transmitted Diseases (STD) Testing Mergers & Acquisitions in the Past Five Years
Table 51. Sexually Transmitted Diseases (STD) Testing New Entrants and Expansion Plans
Table 52. Global Sexually Transmitted Diseases (STD) Testing Revenue (USD Million) by Type (2017-2022)
Table 53. Global Sexually Transmitted Diseases (STD) Testing Revenue Share by Type (2017-2022)
Table 54. Global Sexually Transmitted Diseases (STD) Testing Revenue Forecast by Type (2023-2028)
Table 55. Global Sexually Transmitted Diseases (STD) Testing Revenue by Application (2017-2022)
Table 56. Global Sexually Transmitted Diseases (STD) Testing Revenue Forecast by Application (2023-2028)
Table 57. North America Sexually Transmitted Diseases (STD) Testing Revenue by Type (2017-2022) & (USD Million)
Table 58. North America Sexually Transmitted Diseases (STD) Testing Revenue by Type (2023-2028) & (USD Million)
Table 59. North America Sexually Transmitted Diseases (STD) Testing Revenue by Application (2017-2022) & (USD Million)
Table 60. North America Sexually Transmitted Diseases (STD) Testing Revenue by Application (2023-2028) & (USD Million)
Table 61. North America Sexually Transmitted Diseases (STD) Testing Revenue by Country (2017-2022) & (USD Million)
Table 62. North America Sexually Transmitted Diseases (STD) Testing Revenue by Country (2023-2028) & (USD Million)
Table 63. Europe Sexually Transmitted Diseases (STD) Testing Revenue by Type (2017-2022) & (USD Million)
Table 64. Europe Sexually Transmitted Diseases (STD) Testing Revenue by Type (2023-2028) & (USD Million)
Table 65. Europe Sexually Transmitted Diseases (STD) Testing Revenue by Application (2017-2022) & (USD Million)
Table 66. Europe Sexually Transmitted Diseases (STD) Testing Revenue by Application (2023-2028) & (USD Million)
Table 67. Europe Sexually Transmitted Diseases (STD) Testing Revenue by Country (2017-2022) & (USD Million)
Table 68. Europe Sexually Transmitted Diseases (STD) Testing Revenue by Country (2023-2028) & (USD Million)
Table 69. Asia-Pacific Sexually Transmitted Diseases (STD) Testing Revenue by Type (2017-2022) & (USD Million)
Table 70. Asia-Pacific Sexually Transmitted Diseases (STD) Testing Revenue by Type (2023-2028) & (USD Million)
Table 71. Asia-Pacific Sexually Transmitted Diseases (STD) Testing Revenue by Application (2017-2022) & (USD Million)
Table 72. Asia-Pacific Sexually Transmitted Diseases (STD) Testing Revenue by Application (2023-2028) & (USD Million)
Table 73. Asia-Pacific Sexually Transmitted Diseases (STD) Testing Revenue by Region (2017-2022) & (USD Million)
Table 74. Asia-Pacific Sexually Transmitted Diseases (STD) Testing Revenue by Region (2023-2028) & (USD Million)
Table 75. South America Sexually Transmitted Diseases (STD) Testing Revenue by Type (2017-2022) & (USD Million)
Table 76. South America Sexually Transmitted Diseases (STD) Testing Revenue by Type (2023-2028) & (USD Million)
Table 77. South America Sexually Transmitted Diseases (STD) Testing Revenue by Application (2017-2022) & (USD Million)
Table 78. South America Sexually Transmitted Diseases (STD) Testing Revenue by Application (2023-2028) & (USD Million)
Table 79. South America Sexually Transmitted Diseases (STD) Testing Revenue by Country (2017-2022) & (USD Million)
Table 80. South America Sexually Transmitted Diseases (STD) Testing Revenue by Country (2023-2028) & (USD Million)
Table 81. Middle East & Africa Sexually Transmitted Diseases (STD) Testing Revenue by Type (2017-2022) & (USD Million)
Table 82. Middle East & Africa Sexually Transmitted Diseases (STD) Testing Revenue by Type (2023-2028) & (USD Million)
Table 83. Middle East & Africa Sexually Transmitted Diseases (STD) Testing Revenue by Application (2017-2022) & (USD Million)
Table 84. Middle East & Africa Sexually Transmitted Diseases (STD) Testing Revenue by Application (2023-2028) & (USD Million)
Table 85. Middle East & Africa Sexually Transmitted Diseases (STD) Testing Revenue by Country (2017-2022) & (USD Million)
Table 86. Middle East & Africa Sexually Transmitted Diseases (STD) Testing Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Sexually Transmitted Diseases (STD) Testing Picture
Figure 2. Global Sexually Transmitted Diseases (STD) Testing Revenue Market Share by Type in 2021
Figure 3. Chlamydia
Figure 4. Syphilis
Figure 5. Gonorrhea
Figure 6. Herpes Simplex Virus
Figure 7. Human Papilloma Virus
Figure 8. Human Immunodeficiency Virus
Figure 9. Others
Figure 10. Sexually Transmitted Diseases (STD) Testing Revenue Market Share by Application in 2021
Figure 11. Laboratory Testing Picture
Figure 12. Point of Care (POC) Testing Picture
Figure 13. Global Sexually Transmitted Diseases (STD) Testing Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 14. Global Sexually Transmitted Diseases (STD) Testing Revenue and Forecast (2017-2028) & (USD Million)
Figure 15. Global Sexually Transmitted Diseases (STD) Testing Revenue Market Share by Region (2017-2028)
Figure 16. Global Sexually Transmitted Diseases (STD) Testing Revenue Market Share by Region in 2021
Figure 17. North America Sexually Transmitted Diseases (STD) Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Europe Sexually Transmitted Diseases (STD) Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Asia-Pacific Sexually Transmitted Diseases (STD) Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. South America Sexually Transmitted Diseases (STD) Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. Middle East and Africa Sexually Transmitted Diseases (STD) Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 22. Sexually Transmitted Diseases (STD) Testing Market Drivers
Figure 23. Sexually Transmitted Diseases (STD) Testing Market Restraints
Figure 24. Sexually Transmitted Diseases (STD) Testing Market Trends
Figure 25. ROCHE HOLDINGS Recent Developments and Future Plans
Figure 26. BIOMERIEUX Recent Developments and Future Plans
Figure 27. HOLOGIC Recent Developments and Future Plans
Figure 28. BECTON DICKINSON Recent Developments and Future Plans
Figure 29. ORASURE Recent Developments and Future Plans
Figure 30. DANAHER Recent Developments and Future Plans
Figure 31. AFFYMETRIX Recent Developments and Future Plans
Figure 32. ABBOTT LABORATORIES Recent Developments and Future Plans
Figure 33. BIO-RAD LABORATORIES Recent Developments and Future Plans
Figure 34. DIASORIN Recent Developments and Future Plans
Figure 35. Global Sexually Transmitted Diseases (STD) Testing Revenue Share by Players in 2021
Figure 36. Sexually Transmitted Diseases (STD) Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 37. Global Top 3 Players Sexually Transmitted Diseases (STD) Testing Revenue Market Share in 2021
Figure 38. Global Top 10 Players Sexually Transmitted Diseases (STD) Testing Revenue Market Share in 2021
Figure 39. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 40. Global Sexually Transmitted Diseases (STD) Testing Revenue Share by Type in 2021
Figure 41. Global Sexually Transmitted Diseases (STD) Testing Market Share Forecast by Type (2023-2028)
Figure 42. Global Sexually Transmitted Diseases (STD) Testing Revenue Share by Application in 2021
Figure 43. Global Sexually Transmitted Diseases (STD) Testing Market Share Forecast by Application (2023-2028)
Figure 44. North America Sexually Transmitted Diseases (STD) Testing Sales Market Share by Type (2017-2028)
Figure 45. North America Sexually Transmitted Diseases (STD) Testing Sales Market Share by Application (2017-2028)
Figure 46. North America Sexually Transmitted Diseases (STD) Testing Revenue Market Share by Country (2017-2028)
Figure 47. United States Sexually Transmitted Diseases (STD) Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Canada Sexually Transmitted Diseases (STD) Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Mexico Sexually Transmitted Diseases (STD) Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Europe Sexually Transmitted Diseases (STD) Testing Sales Market Share by Type (2017-2028)
Figure 51. Europe Sexually Transmitted Diseases (STD) Testing Sales Market Share by Application (2017-2028)
Figure 52. Europe Sexually Transmitted Diseases (STD) Testing Revenue Market Share by Country (2017-2028)
Figure 53. Germany Sexually Transmitted Diseases (STD) Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. France Sexually Transmitted Diseases (STD) Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. United Kingdom Sexually Transmitted Diseases (STD) Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Russia Sexually Transmitted Diseases (STD) Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Italy Sexually Transmitted Diseases (STD) Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Asia-Pacific Sexually Transmitted Diseases (STD) Testing Sales Market Share by Type (2017-2028)
Figure 59. Asia-Pacific Sexually Transmitted Diseases (STD) Testing Sales Market Share by Application (2017-2028)
Figure 60. Asia-Pacific Sexually Transmitted Diseases (STD) Testing Revenue Market Share by Region (2017-2028)
Figure 61. China Sexually Transmitted Diseases (STD) Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Japan Sexually Transmitted Diseases (STD) Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South Korea Sexually Transmitted Diseases (STD) Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. India Sexually Transmitted Diseases (STD) Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Southeast Asia Sexually Transmitted Diseases (STD) Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Australia Sexually Transmitted Diseases (STD) Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. South America Sexually Transmitted Diseases (STD) Testing Sales Market Share by Type (2017-2028)
Figure 68. South America Sexually Transmitted Diseases (STD) Testing Sales Market Share by Application (2017-2028)
Figure 69. South America Sexually Transmitted Diseases (STD) Testing Revenue Market Share by Country (2017-2028)
Figure 70. Brazil Sexually Transmitted Diseases (STD) Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Argentina Sexually Transmitted Diseases (STD) Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Middle East and Africa Sexually Transmitted Diseases (STD) Testing Sales Market Share by Type (2017-2028)
Figure 73. Middle East and Africa Sexually Transmitted Diseases (STD) Testing Sales Market Share by Application (2017-2028)
Figure 74. Middle East and Africa Sexually Transmitted Diseases (STD) Testing Revenue Market Share by Country (2017-2028)
Figure 75. Turkey Sexually Transmitted Diseases (STD) Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Sexually Transmitted Diseases (STD) Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. UAE Sexually Transmitted Diseases (STD) Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Methodology
Figure 79. Research Process and Data Source
